GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sona Nanotech Inc (XCNQ:SONA) » Definitions » YoY EBITDA Growth

Sona Nanotech (XCNQ:SONA) YoY EBITDA Growth : 0.00% (As of Jan. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Sona Nanotech YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Sona Nanotech's YoY EBITDA Growth for the quarter that ended in Jan. 2025 was 0.00%.

Sona Nanotech's EBITDA per Share for the three months ended in Jan. 2025 was C$-0.01.


Sona Nanotech YoY EBITDA Growth Historical Data

The historical data trend for Sona Nanotech's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sona Nanotech YoY EBITDA Growth Chart

Sona Nanotech Annual Data
Trend Oct14 Oct15 Oct16 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -145.24 -56.31 80.12 28.13 17.39

Sona Nanotech Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.00 - 28.57 66.67 -

Sona Nanotech YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Sona Nanotech's YoY EBITDA Growth for the fiscal year that ended in Oct. 2024 is calculated as:

YoY EBITDA Growth (A: Oct. 2024 )
=(EBITDA per Share (A: Oct. 2024 )-EBITDA per Share (A: Oct. 2023 ))/ | EBITDA per Share (A: Oct. 2023 ) |
=(-0.019--0.023)/ | -0.023 |
=17.39 %

Sona Nanotech's YoY EBITDA Growth for the quarter that ended in Jan. 2025 is calculated as:

YoY EBITDA Growth (Q: Jan. 2025 )
=(EBITDA per Share (Q: Jan. 2025 )-EBITDA per Share (Q: Jan. 2024 )) / | EBITDA per Share (Q: Jan. 2024 )) |
=(-0.006--0.006)/ | -0.006 |
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sona Nanotech YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Sona Nanotech's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Sona Nanotech Business Description

Traded in Other Exchanges
Address
1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and various biomedical applications. The company's product includes Gemini and Saliva tests.

Sona Nanotech Headlines

No Headlines